Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.45 |
| ▸ | FDPS | P14324 | 1/20 | 0.45 |
| ▸ | BLM | P54132 | 1/20 | 0.45 |
| ▸ | CTSA | P10619 | 1/20 | 0.42 |
| ▸ | ACHE | P22303 | 1/20 | 0.42 |
| ▸ | BTN3A1 | O00481 | 3/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | FNTA | P49354 | 1/20 | 0.33 |
| ▸ | FNTB | P49356 | 1/20 | 0.33 |
| ▸ | MVD | P53602 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28777328 | 0.97 | TDP1 (0.43) | TDP1FDPSBLMCTSAACHE | |
| SCHEMBL28777336 | 0.97 | TDP1 (0.43) | TDP1FDPSBLMCTSAACHE | |
| SCHEMBL13163298 | 0.95 | TDP1 (0.41) | TDP1FDPSBLMCTSAACHE | |
| SCHEMBL1071892 | 0.89 | CTSA (0.46) | TDP1FDPSBLMCTSAACHE | |
| Propene SCHEMBL15540548 | 0.89 | BTN3A1 (0.37) | TDP1FDPSBLMCTSAACHE | |
| SCHEMBL13163286 | 0.84 | FDPS (0.36) | TDP1FDPSBLMCTSAACHE | |
| SCHEMBL268599 | 0.83 | CTSA (0.50) | TDP1FDPSBLMCTSAACHE | |
| SCHEMBL29072173 | 0.82 | CTSA (0.40) | TDP1FDPSBLMCTSAACHE | |
| SCHEMBL27503366 | 0.82 | FDPS (0.43) | TDP1FDPSBLMBTN3A1FNTA | |
| SCHEMBL19977202 | 0.82 | CTSA (0.40) | TDP1FDPSBLMCTSAACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119707355-A | Road paving material with solid waste as aggregate, and preparation method and application thereof | 北京建筑大学 | 2025-03-28 | — | — | CN | claimed |
| CN-112993289-A | Lithium/carbon fluoride battery, electrolyte thereof and use method thereof | 中国科学院大连化学物理研究所 | 2021-06-18 | — | — | CN | claimed |
| US-9453244-B2 | Method for producing a monoalkene by enzymatic conversion of an alkyl monoester | GLOBAL BIOENERGIES (FR) | 2016-09-27 | — | — | US | claimed |
| US-20150159177-A1 | METHOD FOR PRODUCING A MONOALKENE BY ENZYMATIC CONVERSION OF AN ALKYL MONOESTER | GLOBAL BIOENERGIES (FR) | 2015-06-11 | — | — | US | claimed |
| EP-2867365-A1 | PROCESS FOR PRODUCING A C2-C10 MONOALKENE EMPLOYING A TERPENE SYNTHASE OR A PRENYL TRANSFERASE | Scientist of Fortune S.A. (LU) | 2015-05-06 | — | — | EP | claimed |
| WO-2014001517-A1 | PROCESS FOR PRODUCING A C2-C10 MONOALKENE EMPLOYING A TERPENE SYNTHASE OR A PRENYL TRANSFERASE | SCIENTIST OF FORTUNE S.A. (LU) | 2014-01-03 | — | — | WO | claimed |
| US-5639653-A | ADMINISTERING MONOALKYL- OR ALKENYL-PYROPHOSPHATE TO MAMMAL TO STIMULATE LYMPHOCYTE CELL GROWTH AND ENHANCE IMMUNE RESPONSE | ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY, A DIVISION OF YESHIVA UNIVERSTIY (US) | 1997-06-17 | — | — | US | claimed |
| CN-119707355-A | Road paving material with solid waste as aggregate, and preparation method and application thereof | 北京建筑大学 | 2025-03-28 | — | — | CN | disclosed |
| US-11839658-B2 | Aminoglycoside derivatives and nano-assemblies thereof, including those with quorum sensing inhibitory function | Helmholtz-Zentrum für Infektionsforschung GmbH (DE) | 2023-12-12 | — | — | US | disclosed |
| EP-4277731-A1 | MEMBRANE FOR WATER FILTRATION | Aquaporin A/S (DK) | 2023-11-22 | — | — | EP | disclosed |
| US-20230295437-A1 | SILICON CONTAINING DETECTABLE COMPOUNDS | Singular Genomics Systems, Inc. | 2023-09-21 | — | — | US | disclosed |
| CN-116745025-A | membrane for water filtration | 水通道蛋白有限公司 | 2023-09-12 | — | — | CN | disclosed |
| US-20230257414-A1 | NUCLEOTIDE ANALOGUES | FIRST-CITIZENS BANK & TRUST COMPANY | 2023-08-17 | — | — | US | disclosed |
| CN-103098291-A | Non-aqueous electrolyte secondary battery | ADEKA CORP | 2013-05-08 | — | — | CN | disclosed |
| CN-103038931-A | Non-aqueous electrolyte secondary battery | ADEKA CORP | 2013-04-10 | — | — | CN | disclosed |
| US-7858661-B2 | Protein refolding agent and refolding method | SANYO CHEMICAL INDUSTRIES, LTD. (JP) | 2010-12-28 | — | — | US | disclosed |
| US-20100168403-A1 | Protein refolding agent and refolding method | YAMAGUCHI SHUNICHLRO | 2010-07-01 | — | — | US | disclosed |
| US-20090111971-A1 | PROTEIN REFOLDING AGENT AND REFOLDING METHOD | SANYO CHEMICAL INDUSTRIES, LTD. (JP) | 2009-04-30 | — | — | US | disclosed |
| US-5902793-A | ADMINISTERING TO MAMMAL GAMMA-MONOALKYL- OR GAMMA-ALKENYL-NUCLEOSIDE OR DEOXYNUCLEOSIDE TRIPHOSPHATE | ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY (US) | 1999-05-11 | — | — | US | disclosed |
| US-5639653-A | ADMINISTERING MONOALKYL- OR ALKENYL-PYROPHOSPHATE TO MAMMAL TO STIMULATE LYMPHOCYTE CELL GROWTH AND ENHANCE IMMUNE RESPONSE | ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY, A DIVISION OF YESHIVA UNIVERSTIY (US) | 1997-06-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090111971-A1 | PROTEIN REFOLDING AGENT AND REFOLDING METHOD | HSPA5, HSPBP1, RRBP1 | TDP1 456/4885FDPS 532/4885BLM 3232/4885 |
| US-20230295437-A1 | SILICON CONTAINING DETECTABLE COMPOUNDS | AS3MT, SCLY, NASP | TDP1 1096/4885FDPS 1155/4885BLM 239/4885 |
| US-11839658-B2 | Aminoglycoside derivatives and nano-assemblies thereof, including those with quorum sensing inhibitory function | FNTA, FNTB, FDPS | TDP1 4313/4885FDPS 3/4885BLM 2585/4885 |
| US-20100168403-A1 | Protein refolding agent and refolding method | HSPA5, HSPBP1, RRBP1 | TDP1 384/4885FDPS 566/4885BLM 3143/4885 |
| US-20230257414-A1 | NUCLEOTIDE ANALOGUES | ITPA, POLB, NUDT1 | TDP1 205/4885FDPS 224/4885BLM 168/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.